305 related articles for article (PubMed ID: 29860106)
1. GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation.
Li J; Zhang Y; Zhang Y; Lü S; Miao Y; Yang J; Huang S; Ma X; Han L; Deng J; Fan F; Liu B; Huo Y; Xu Q; Chen C; Wang X; Feng J
Redox Biol; 2018 Jul; 17():386-399. PubMed ID: 29860106
[TBL] [Abstract][Full Text] [Related]
2. PKM2-dependent metabolic reprogramming in CD4
Lü S; Deng J; Liu H; Liu B; Yang J; Miao Y; Li J; Wang N; Jiang C; Xu Q; Wang X; Feng J
J Mol Med (Berl); 2018 Jun; 96(6):585-600. PubMed ID: 29732501
[TBL] [Abstract][Full Text] [Related]
3. Shikonin attenuates hyperhomocysteinemia-induced CD4
Lü SL; Dang GH; Deng JC; Liu HY; Liu B; Yang J; Ma XL; Miao YT; Jiang CT; Xu QB; Wang X; Feng J
Acta Pharmacol Sin; 2020 Jan; 41(1):47-55. PubMed ID: 31607752
[TBL] [Abstract][Full Text] [Related]
4. Hypercysteinemia promotes atherosclerosis by reducing protein S-nitrosylation.
Chen Y; Liu R; Zhang G; Yu Q; Jia M; Zheng C; Wang Y; Xu C; Zhang Y; Liu E
Biomed Pharmacother; 2015 Mar; 70():253-9. PubMed ID: 25776509
[TBL] [Abstract][Full Text] [Related]
5. AKR1A1 is a novel mammalian
Stomberski CT; Anand P; Venetos NM; Hausladen A; Zhou HL; Premont RT; Stamler JS
J Biol Chem; 2019 Nov; 294(48):18285-18293. PubMed ID: 31649033
[TBL] [Abstract][Full Text] [Related]
6. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H
Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319
[TBL] [Abstract][Full Text] [Related]
7. Improvement in Outcomes After Cardiac Arrest and Resuscitation by Inhibition of S-Nitrosoglutathione Reductase.
Hayashida K; Bagchi A; Miyazaki Y; Hirai S; Seth D; Silverman MG; Rezoagli E; Marutani E; Mori N; Magliocca A; Liu X; Berra L; Hindle AG; Donnino MW; Malhotra R; Bradley MO; Stamler JS; Ichinose F
Circulation; 2019 Feb; 139(6):815-827. PubMed ID: 30586713
[TBL] [Abstract][Full Text] [Related]
8. Enhancing S-nitrosoglutathione reductase decreases S-nitrosylation of Drp1 and reduces neuronal apoptosis in experimental subarachnoid hemorrhage both in vivo and in vitro.
Wang L; Wang Z; You W; Yu Z; Li X; Shen H; Li H; Sun Q; Li W; Chen G
Brain Res Bull; 2022 Jun; 183():184-200. PubMed ID: 35304287
[TBL] [Abstract][Full Text] [Related]
9. Transnitrosylation: A Factor in Nitric Oxide-Mediated Penile Erection.
Musicki B; Lagoda G; Goetz T; La Favor JD; Burnett AL
J Sex Med; 2016 May; 13(5):808-814. PubMed ID: 27114194
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced changes in protein s-nitrosylation in female mouse brainstem.
Palmer LA; Kimberly deRonde ; Brown-Steinke K; Gunter S; Jyothikumar V; Forbes MS; Lewis SJ
Am J Respir Cell Mol Biol; 2015 Jan; 52(1):37-45. PubMed ID: 24922346
[TBL] [Abstract][Full Text] [Related]
11. Chronicles of a reductase: Biochemistry, genetics and physio-pathological role of GSNOR.
Rizza S; Filomeni G
Free Radic Biol Med; 2017 Sep; 110():19-30. PubMed ID: 28533171
[TBL] [Abstract][Full Text] [Related]
12. Balance between
Yamashita AMS; Ancillotti MTC; Rangel LP; Fontenele M; Figueiredo-Freitas C; Possidonio AC; Soares CP; Sorenson MM; Mermelstein C; Nogueira L
Am J Physiol Cell Physiol; 2017 Jul; 313(1):C11-C26. PubMed ID: 28381519
[TBL] [Abstract][Full Text] [Related]
13. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.
Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H
Circ Res; 2012 Jun; 111(1):37-49. PubMed ID: 22628578
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice.
Zhang D; Jiang X; Fang P; Yan Y; Song J; Gupta S; Schafer AI; Durante W; Kruger WD; Yang X; Wang H
Circulation; 2009 Nov; 120(19):1893-902. PubMed ID: 19858416
[TBL] [Abstract][Full Text] [Related]
15. O-Aminobenzoyl-S-nitrosoglutathione: A fluorogenic, cell permeable, pseudo-substrate for S-nitrosoglutathione reductase.
Sun BL; Palmer L; Alam SR; Adekoya I; Brown-Steinke K; Periasamy A; Mutus B
Free Radic Biol Med; 2017 Jul; 108():445-451. PubMed ID: 28419866
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice.
Feng J; Zhang Z; Kong W; Liu B; Xu Q; Wang X
Cardiovasc Res; 2009 Oct; 84(1):155-63. PubMed ID: 19502284
[TBL] [Abstract][Full Text] [Related]
17. Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis.
Dai J; Li W; Chang L; Zhang Z; Tang C; Wang N; Zhu Y; Wang X
Free Radic Biol Med; 2006 Nov; 41(10):1566-77. PubMed ID: 17045925
[TBL] [Abstract][Full Text] [Related]
18. Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action.
Jiang H; Polhemus DJ; Islam KN; Torregrossa AC; Li Z; Potts A; Lefer DJ; Bryan NS
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):478-85. PubMed ID: 26746429
[TBL] [Abstract][Full Text] [Related]
19. S-nitrosylation/denitrosylation and apoptosis of immune cells.
Duan S; Chen C
Cell Mol Immunol; 2007 Oct; 4(5):353-8. PubMed ID: 17976315
[TBL] [Abstract][Full Text] [Related]
20. Altered Plant and Nodule Development and Protein S-Nitrosylation in Lotus japonicus Mutants Deficient in S-Nitrosoglutathione Reductases.
Matamoros MA; Cutrona MC; Wienkoop S; Begara-Morales JC; Sandal N; Orera I; Barroso JB; Stougaard J; Becana M
Plant Cell Physiol; 2020 Jan; 61(1):105-117. PubMed ID: 31529085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
